Literature DB >> 13638794

Improvement of the antigenicity of antirabies vaccine by pooling checked by post-challenge vaccination of guinea-pigs.

N VEERARAGHAVAN.   

Abstract

The author describes some studies carried out at the Pasteur Institute of Southern India, Coonoor, with the object of developing an antirabies vaccine of uniform potency.It was found that by pooling batches of vaccine from several infected sheep brains a vaccine was produced which was superior in antigenicity (as determined by potency tests in mice) to the NIH (United States National Institutes of Health) Reference Vaccine 155-D as well as to most of the individual batches of vaccine tested. Furthermore, the pooled vaccine conferred a significant degree of protection on guinea-pigs challenged with virulent strains of street virus, even when not administered until an hour after infection.A brief outline is given of the method used for pooling the vaccine.

Entities:  

Keywords:  RABIES/immunology

Mesh:

Substances:

Year:  1959        PMID: 13638794      PMCID: PMC2537804     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Advances in rabies treatment; an experimental evaluation.

Authors:  N VEERARAGHAVAN; A BALASUBRAMANIAN; T P SUBRAHMANYAN
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

2.  Preparation of lyophilized rabies street virus material from infective submaxillary glands for challenge purposes.

Authors:  N VEERARAGHAVAN
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

  2 in total
  6 in total

1.  Antigenic value of lyophilized phenolized antirabies vaccine.

Authors:  N VEERARAGHAVAN; T P SUBRAHMANYAN
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

2.  Value of antirabies vaccine with and without serum against severe challenges.

Authors:  N VEERARAGHAVAN; T P SUBRAHMANYAN
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

3.  Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.

Authors:  Aisling O'Dowd; Milton Maciel; Steven T Poole; Michael G Jobling; Julianne E Rollenhagen; Colleen M Woods; Stephanie A Sincock; Annette L McVeigh; Michael J Gregory; Ryan C Maves; Michael G Prouty; Randall K Holmes; Stephen J Savarino
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

4.  DURATION OF IMMUNITY TO REINFECTION IN GUINEA-PIGS TREATED WITH ANTIRABIES SERUM AND VACCINE, AND THE VALUE OF BOOSTER DOSES OF VACCINE IN RE-TREATMENT.

Authors:  N VEERARAGHAVAN; T P SUBRAHMANYAN
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

5.  THE VALUE OF DUCK-EMBRYO VACCINE AND HIGH-EGG-PASSAGE FLURY VACCINE IN EXPERIMENTAL RABIES INFECTION IN GUINEA-PIGS.

Authors:  N VEERARAGHAVAN; T P SUBRAHMANYAN
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

6.  Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.

Authors:  Katherine Schultheis; Hubert Schaefer; Bryan S Yung; Janet Oh; Karuppiah Muthumani; Laurent Humeau; Kate E Broderick; Trevor R F Smith
Journal:  Vaccine       Date:  2016-11-25       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.